Jan Rosenbaum

Dr. Jan S. Rosenbaum, CSO, has more than 20 years of drug development experience. Jan held technical management positions in big pharma (P&G pharmaceuticals) where she led efforts on the development of small molecule, peptide, and protein therapeutics. She joined CincyTech in 2009 as Director of Life Sciences with responsibility for creating life science startup companies in the southwest Ohio region and has been involved with Airway since its initial financing round. Jan’s areas of expertise are in Molecular Pharmacology and Developmental Biology. She has authored over 50 publications and is an inventor on multiple US and foreign patents.

Jan holds a Ph.D. in Pharmaceutical Chemistry from UCSF and a postdoctoral fellowship in Clinical Pharmacology from Stanford University.

Jan Rosenbaum is the President, CEO, & CSO at Kurome Therapeutics, based in United States, North America. With a background in Biotechnology, Jan Rosenbaum has a rich history of leadership and innovation.Jan Rosenbaum studied Ph.D. Pharmaceutical Chemistry at University of California, San Francisco. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.